Co-Diagnostics, Inc. Deferred Income Period Increase Decrease
Co-Diagnostics, Inc. (CODX) reported Deferred Income Period Increase Decrease of -$19.62 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredIncomePeriodIncreaseDecrease · last filed 2025-03-27
- Co-Diagnostics, Inc. deferred income period increase decrease for fiscal 2024 was -$19.62K.
| Period end | Deferred Income Period Increase Decrease 12 month |
|---|---|
| 2024-12-31 | -$19.62K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |